vancomycin has been researched along with Canine Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, LN; da Silva, GR; de Almeida Martins, L; de Paula Ferreira, LR; Dos Santos, IC; Dos Santos, MC; Gonçalves, DD; Otutumi, LK; Zaniolo, MM | 1 |
| D Andrade, AC; da Silva, LCBA; de Oliveira Santos, LM; Lincopan, N; Sacramento, AG; Sellera, FP; Teotonio, BN | 1 |
| Allerberger, F; Barf, LM; Burgener, IA; Cabal, A; Ehricht, R; Feßler, AT; Finsterwalder, SK; Künzel, F; Loncaric, I; Marz, M; Monecke, S; Ruppitsch, W; Schwarz, S; Spergser, J; Szostak, MP; Tichy, A | 1 |
| Pintarić, S; Štritof, Z; Tumpa, A | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
| Babyak, JM; DeStefano, IM; Rozanski, EA; Wayne, AS | 1 |
| Matsue, K; Nishida, Y; Sugihara, H; Takeuchi, M; Ugai, T; Yamakura, M | 1 |
| Cushman, M; Hammac, GK; Mayhoub, AS; Mohammad, H; Monteleone, D; Reddy, PV; Seleem, MN | 1 |
| Weese, JS | 1 |
| Au, J; Bolin, C; Malani, AN; Rutland, BE; Weese, JS | 1 |
| Donabedian, SM; English, LL; Hayes, JR; McDermott, PF; Simjee, S; Wagner, DD; Walker, RD; White, DG; Zervos, MJ | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Herrero, IA; Moreno, MA | 1 |
12 other study(ies) available for vancomycin and Canine Diseases
| Article | Year |
|---|---|
Pet dogs as reservoir of oxacillin and vancomycin-resistant Staphylococcus spp.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Dog Diseases; Dogs; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus; Vancomycin | 2022 |
WHO critical priority van-type vancomycin-resistant Enterococcus in dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cat Diseases; Cats; Dog Diseases; Dogs; Enterococcus; Microbial Sensitivity Tests; Vancomycin; World Health Organization | 2022 |
Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Dog Diseases; Dogs; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tetracyclines; Vancomycin | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |
Parenterally administered vancomycin in 29 dogs and 7 cats (2003-2017).
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Injections, Intravenous; Male; Retrospective Studies; Vancomycin | 2019 |
Capnocytophaga canimorsus sepsis following BMT in a patient with AML: possible association with functional asplenia.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Disease Progression; Dog Diseases; Dogs; Female; Graft vs Host Disease; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Postoperative Complications; Saliva; Sepsis; Spleen; Thienamycins; Thrombocytosis; Treatment Outcome; Vancomycin | 2014 |
Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dog Diseases; Dogs; Lysostaphin; Methicillin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus; Thiazoles; Vancomycin | 2015 |
Issues regarding the use of vancomycin in companion animals.
Topics: Animals; Dog Diseases; Dogs; Enterococcus; Gram-Positive Bacterial Infections; Humans; Legislation, Drug; Legislation, Veterinary; Methicillin Resistance; Public Health; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Human-to-dog transmission of methicillin-resistant Staphylococcus aureus.
Topics: Aged; Animals; Anti-Bacterial Agents; Communicable Diseases, Emerging; Dog Diseases; Dogs; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Zoonoses | 2009 |
Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gene Transfer, Horizontal; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Plasmids; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2002 |
Dogs should be included in surveillance programs for vancomycin-resistant enterococci.
Topics: Animals; Dog Diseases; Dogs; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Population Surveillance; Vancomycin | 2004 |